Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Short-term oral magnesium supplementation suppresses bone turnover in postmenopausal osteoporotic women.

Aydin H, Deyneli O, Yavuz D, Gözü H, Mutlu N, Kaygusuz I, Akalin S.

Biol Trace Elem Res. 2010 Feb;133(2):136-43. doi: 10.1007/s12011-009-8416-8.

PMID:
19488681
4.

Effects of recombinant insulin-like growth factor-I and growth hormone on bone turnover in elderly women.

Ghiron LJ, Thompson JL, Holloway L, Hintz RL, Butterfield GE, Hoffman AR, Marcus R.

J Bone Miner Res. 1995 Dec;10(12):1844-52.

PMID:
8619364
5.

Daily oral magnesium supplementation suppresses bone turnover in young adult males.

Dimai HP, Porta S, Wirnsberger G, Lindschinger M, Pamperl I, Dobnig H, Wilders-Truschnig M, Lau KH.

J Clin Endocrinol Metab. 1998 Aug;83(8):2742-8.

PMID:
9709941
6.
7.

Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.

Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD.

J Bone Miner Res. 1996 Mar;11(3):337-49.

PMID:
8852944
8.

Effects of chronic liver disease on bone mineral density and bone metabolism markers in postmenopausal women.

Uretmen S, Gol M, Cimrin D, Irmak E.

Eur J Obstet Gynecol Reprod Biol. 2005 Nov 1;123(1):67-71.

PMID:
16051419
9.

Effect of potassium citrate supplementation or increased fruit and vegetable intake on bone metabolism in healthy postmenopausal women: a randomized controlled trial.

Macdonald HM, Black AJ, Aucott L, Duthie G, Duthie S, Sandison R, Hardcastle AC, Lanham New SA, Fraser WD, Reid DM.

Am J Clin Nutr. 2008 Aug;88(2):465-74.

11.
12.

Comparison of the effects of alendronate and risedronate on bone mineral density and bone turnover markers in postmenopausal osteoporosis.

Sarioglu M, Tuzun C, Unlu Z, Tikiz C, Taneli F, Uyanik BS.

Rheumatol Int. 2006 Jan;26(3):195-200.

PMID:
15580349
13.

Short-term treatment with growth hormone stimulates osteoblastic and osteoclastic activity in osteopenic postmenopausal women: a dose response study.

Brixen K, Kassem M, Nielsen HK, Loft AG, Flyvbjerg A, Mosekilde L.

J Bone Miner Res. 1995 Dec;10(12):1865-74.

PMID:
8619366
14.

Longitudinal changes of bone mineral density and bone turnover in postmenopausal women on thyroxine.

Guo CY, Weetman AP, Eastell R.

Clin Endocrinol (Oxf). 1997 Mar;46(3):301-7.

PMID:
9156039
15.

Oral 1,25-dihydroxyvitamin D administration in osteoporotic women: effects of estrogen therapy.

Cosman F, Nieves J, Shen V, Lindsay R.

J Bone Miner Res. 1995 Apr;10(4):594-600.

PMID:
7610930
17.

Effect of phylloquinone supplementation on biochemical markers of vitamin K status and bone turnover in postmenopausal women.

Bügel S, Sørensen AD, Hels O, Kristensen M, Vermeer C, Jakobsen J, Flynn A, Mølgaard C, Cashman KD.

Br J Nutr. 2007 Feb;97(2):373-80.

PMID:
17298708
18.

Serum osteocalcin and urinary crosslaps are suitable markers of bone turnover in response to short-term hormone replacement therapy.

Peichl P, Griesmacher A, Müller MM, Marteau R, Kumpan W, Bröll H.

Gynecol Endocrinol. 2000 Oct;14(5):374-81.

PMID:
11109977
19.

Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis.

Verit FF, Geyikli I, Yazgan P, Celik A.

Arch Gynecol Obstet. 2006 Jun;274(3):133-7.

PMID:
16532321
20.
Items per page

Supplemental Content

Support Center